c-Fms

Colony stimulating factor 1 receptor (CSF1R), also known as macrophage colony-stimulating factor receptor (M-CSFR), and CD115 (Cluster of Differentiation 115), is a cell-surface protein encoded, in humans, by the CSF1R gene (known also as c-FMS). It is a receptor for a cytokine called colony stimulating factor 1.

Cat. No.	Product name	CAS No.	Purity
T10643	C-Fms-IN-1	885703-64-0	98%
T10643	c-Fms-IN-1 is an inhibitor of c-FMS kinase (IC50 = 0.8 nM).
T10648	C-Fms-IN-9	1628574-50-4	98%
T10648	c-Fms-IN-9 is a c-FMS inhibitor extracted from patent WO2014145023A1 (Example 7). It inhibits unphosphorylated c-FMS kinase (uFMS) and uKIT (IC50s: <0.01 μM and ...
T10649	C-Fms-IN-3	885704-21-2	98%
T10649	c-Fms-IN-3 is a novel inhibitor of the c-FMS and can be used in studies about antirheumatic and anti-inflammatory diseases.
T6104	Cerdulatinib hydrochloride	1369761-01-2	98%
T6104	Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and S...
T1925	PLX647	873786-09-5	98%
T1925	PLX647 is a highly selective dual FMS/KIT kinase inhibitor (IC50: 28/16 nM).
T61589	C-Fms-IN-13	885704-58-5	98%
T61589	c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50= 17 nM). c-Fms-IN-13 is an anti-inflammatory agent.
T12505	PLX5622 hemifumarate	T12505	98%
T12505	PLX5622 hemifumarate is a highly selective brain penetrant and orally active CSF1R inhibitor with an IC 50 of 0.016 μM and Ki of 5.9 nM. PLX5622 hemifumarate all...
T11734	K-80003	1292821-90-9	98%
T11734	K-80003 is a potent inhibitor of cancer cell growth and tRXRα-dependent Akt activation.
T10645	C-Fms-IN-6	1628574-81-1	98%
T10645	c-Fms-IN-6 is a potent inhibitor of c-FMS (IC50 ≤10 nM for unphosphorylated c-FMS) and also weakly inhibits unphosphorylated c-KIT and PDGFR (IC50: > 1 μM).
T35570	Chiauranib	1256349-48-0	96.25%
T35570	Chiauranib is a multi-target inhibitor against tumor angiogenesis and exhibits potent anticancer effects. Chiauranib potently inhibits the angiogenesis-related k...
T10775	C-Fms-IN-2	791587-67-2	97.34%
T10775	c-Fms-IN-2 is an inhibitor of c-FMS kinase (IC50 = 24 nM).
T2116	AEE788	497839-62-0	98%
T2116	AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.
T6028	PF 477736	952021-60-2	98.34%
T6028	PF-477736 is a specifc, effective and ATP-competitive Chk1 inhibitor (Ki: 0.49 nM ) and also inhibits FGFR3, Aurora-A, VEGFR2, Flt3, Fms (CSF1R), Ret and Yes.
T10894	CSF1R-IN-1	2095849-04-8	98.57%
T10894	CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.
T10652	Vimseltinib	1628606-05-2	98.98%
T10652	DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).
T2514	Linifanib	796967-16-3	99.29%
T2514	Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR (IC50: 4 nM), CSF-1R (IC50: 3 nM), Flt-1/3 (IC50: 3/4 nM) and PDGFRβ (IC50: ...
T4315	Ki20227	623142-96-1	99.37%
T4315	Ki-20227 is a specific c-Fms tyrosine kinase(CSF1R) inhibitor (IC50: 2 nM). It also has certain inhibitory against VEGFR2(IC50: 12 nM) and c-Kit/PDGFRβ(IC50: 451...
T4376	Nampt-IN-1	1698878-14-6	99.4%
T4376	Nampt-IN-1 (LSN3154567) is a potent and selective NAMPT inhibitor. Nampt-IN-1 inhibits purified NAMPT with an IC50 of 3.1 nM.
T2659	GW2580	870483-87-7	99.48%
T2659	GW2580 is a specific, oral-bioavailable CSF-1R inhibitor for c-FMS.
T2115	Pexidartinib	1029044-16-3	99.66%
T2115	Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic a...